The AeroForm chest wall tissue expander (TE) is a silicon shell containing a metallic CO 2 reservoir, placed surgically after mastectomy. The patient uses a remote control to release compressed CO 2 from the reservoir to inflate the expander. AeroForm poses challenges in a radiation therapy setting: The high density of the metallic reservoir causes imaging artifacts on the planning CT, which encumber structure definition and cause misrepresentation of density information, in turn affecting dose calculation. Additionally, convolution-based dose calculation algorithms may not be well-suited to calculate dose in and around high-density materials. In this study, a model of the AeroForm TE was created in Eclipse treatment planning system (TPS). The TPS model was validated by comparing measured to calculated transmission through the 
| INTRODUCTION
For breast cancer patients with greater than four positive lymph nodes, positive or close margins, or a tumor greater than 5 cm, the National Comprehensive Cancer Network guidelines recommend postmastectomy radiation therapy (PMRT). Currently there is no consensus on the optimal method and timing of postmastectomy breast reconstruction for patients receiving PMRT. [1] [2] [3] One common technique is the two-stage breast reconstruction. In this method, a tissue expander (TE) is placed at the time of mastectomy. In the following weeks, the TE is gradually expanded to the desired size, and PMRT is delivered after expansion is complete. At a later time, the TE is exchanged for a permanent implant. [4] [5] [6] Several types of TEs are available. The CPX® (Mentor, Irvine, CA, USA), Natrelle® (ALLERGAN, Santa Barbara, CA, USA), Dermaspan TM and AlloX 2 ® (Sientra, INC., Santa Barbara, CA, USA)
TEs consists of a silicon shell containing a magnetic injection port.
The TE is expanded by externally aligning a magnetic port locating device to the internal magnetic port (IMP). Once aligned, saline is injected percutaneously through the IMP to inflate the TE.
Patients receive weekly injections, over the course of 6-8 weeks. 7, 8 The AeroForm TE (AirXpanders, Palo Alto, CA, USA) consists of a silicon shell containing a stainless steel reservoir of compressed CO 2 .
The TE is expanded using a hand-held remote control, which sends a radio-frequency signal to the expander. The TE in turn releases small volumes of compressed CO 2 from the reservoir into the silicon shell.
The expansion is patient controlled; typically a patient releases 10 cc CO 2 at a time, up to three times per day, over the course of 4-6 weeks. If radiation is indicated, the patient is typically simulated and treated after expansion is complete. 8, 9 Tissue expanders pose particular challenges in a radiation oncology setting. The high-density metallic components of both types of TE cause artifacts in treatment planning CT images. The degradation of image quality makes target definition more challenging, and misrepresentation of CT number in and around the TE may cause errors in dose calculation. 16-bit CT reconstruction corrected using metal artifact reduction (MAR) reconstruction techniques may minimize the effects of artifacts on image quality. 10, 11 However, even with accurate CT information, convolution dose calculation algorithms are not designed for use with high-Z materials. 12, 13 Previous literature has proposed various solutions dealing with TEs in a radiation treatment planning systems (TPS). 14 Chen et al. This study aims first to describe a method for modelling the AeroForm in Eclipse TPS. It is the authors' hope that the procedure can be easily implemented into any clinician's radiation therapy TPS.
The TPS model will be optimized and evaluated for both AAA and AXB, employing techniques described Chen et al and Yoon et al.
Finally, the dosimetric impact of the AeroForm TE will be evaluated using clinical patient data. Differences in plan outcome based on dose calculation algorithm will be discussed. An understanding of dose calculation accuracy in the vicinity of the AeroForm TE is critical for assessing individual plan quality, appropriateness of different planning techniques and dose calculation algorithms, and even the decision to use the AeroForm TE in a PMRT setting.
| MATERIALS AND METHODS

2.A | Imaging and modeling the AeroForm TE
The AeroForm TE is available in three sizes: 400, 600, and 800 cc.
The 400 and 600 cc sizes utilize a CO 2 reservoir 7.6 cm in length and 1.9 cm in diameter. The 800 cc TE uses a reservoir 9.0 cm in length and 1.9 cm in diameter. Both sizes of AeroForm reservoir are shown in Fig. 1 , with the Natrelle® IMP for comparison.
Each reservoir size was imaged using a Philips Brilliance Big Bore CT scanner (Philips Health Care, Cleveland, OH, USA). The AeroForm reservoir was aligned such that the long axis was perpendicular to axial plane, so as to minimize artifacts. Helical CTs were acquired for a 20 cm FOV with a 1 mm slice thickness using 120 kVp and 500 mAs. A 16-bit reconstruction was generated.
TPS models of both CO 2 reservoir sizes were created in Eclipse (platform 13.5). The CT scans were imported into the TPS and individual components were identified and contoured using automatic 
2.B | Validation of the AeroForm TPS model
Several simple geometries were used to validate the TE models. Each In the planning CT, density overrides were applied to the air and solid water to correct for artifacts. Initially, CT values of the various components of the CO 2 reservoir were assigned based on manufacturer specifications. In AAA, initial CT values were assigned to achieve a physical density as near as possible to the vendor-stated physical density. In AXB, initial CT values were assigned based on the Eclipse default material values for stainless steel. Upon analysis, the densities of the various AeroForm components were adjusted to best fit measured data. Re-assignment of CT value, dose calculation, and comparison to measured data was then repeated iteratively to identify the optimal density assignments that resulted in the best agreement between measured and calculated data for both AAA and AXB.
2.C | Evaluation of the AeroForm TPS model in clinical cases
Patient data were analyzed as part of an IRB-approved retrospective study. Four postmastectomy patients with AeroForm TEs were simu- 
Coronal CT slice of the 400-600 cc AeroForm CO 2 reservoir using optimal geometry and acquisition technique. Individual components are defined and verified with manufacturer specifications.
F I G . 3. Bilateral AeroForm implants cause significant artifacts in the patient CT. Reservoir components are defined by registering the patient CT with to the treatment planning system model (shown in the "moving window"). The optimized CT values (Table 2) were assigned to all CO 2 reservoir components. Additionally, density overrides were applied to the expander balloon and PTV_EVAL structures to correct for streaking artifacts. Density overrides were only necessary in the CT slices where the CO 2 reservoir was visible.
An experienced dosimetry team planned all four cases using 6 MV tangential geometries. All plans included the use of 0.5 cm of bolus over the entire breast every other day. Planning goals for AeroForm structures are shown in Table 1 . Dose distributions were optimized using electronic tissue compensation (ECOMP) technique.
To achieve acceptable coverage, the dose shadow and chest wall regions were "boosted." An example of the resulting fluence is shown in Fig. 6 .
Initial planning employed AAA dose calculation algorithm. After a satisfactory plan was achieved and reviewed by a physician, each plan was re-calculated using AXB dose calculation algorithm. Beam parameters were unchanged. Patients 1, 3, and 4 were planned to a total dose of 50 Gy, and patient 2 was planned to a total dose of 50.4 Gy.
Dose distributions calculated by AAA and AXB were compared by evaluating dose volume histograms (DVHs) of the structures of interest defined above. For each of the patient, the mean (D mean ) and maximum (D max ) dose of each structure was tabulated for both the AAA-and AXB-calculated plan. The differences between values calculated by the two algorithms are reported.
| RESULTS & DISCUSSION
3.A | Imaging and modeling the AeroForm TE
Using optimal geometry and imaging technique, the AeroForm CO 2 reservoir alone can be exquisitely imaged without a MAR reconstruction. The CT technique described previously was used to create the TPS models of the AeroForm device in Eclipse TPS (Fig. 2) . Measured dimensions of the stainless steel CO 2 bottle and the stainless steel and copper windings (SSCW) agreed within 1 mm of vendor provided specifications. Additionally, the TPS model included the rubber cap, for which the vendor did not provide specifications.
Unfortunately, such a CT technique is not practical for a patient breast simulation. First, the AeroForm TE is surgically placed with the long axis parallel to the axial plane. It is not possible to orient the patient on the CT to achieve the optimal imaging of the reservoir. Furthermore, many patients have bilateral TEs, increasing the streaking artifact effect on the axial slices where both reservoirs are visible. Finally, a small FOV, 1-mm slice thickness CT protocol is not suitable for a breast CT acquisition.
Both reconstructions were made available during contouring, but the non-MAR reconstruction was used as the primary planning CT.
Planners observed that the MAR reconstruction offered better visualization of the CO 2 reservoir and the external contour. However, near tissue-air cavity interfaces such as the chest wall-lung or PTV_EVAL-expander balloon boundaries, the MAR reconstruction sometimes generated high-density "cavity filling" artifacts, as shown in Fig. 7 . Therefore, the non-MAR reconstruction was more useful in 
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defining the lungs and the expander balloon. Due to the severe streaking artifacts (particularly where patients had bilateral expanders), lung and external structures created using the auto-contouring tools required manual editing on slices where the reservoir was visible.
3.B | Validation of the AeroForm TPS model
Transmission through the AeroForm CO 2 reservoir was best modelled using the RED assignments shown in Table 2 . Figure 8 compares the measured and calculated dose profiles along the long axis of the AeroForm for the horizontal geometry [ Fig. 4(a) ]. Calculated dose profiles are shown before and after the RED assignments were optimized, for both AAA and AXB. In AAA, the initial model (which assigned densities based on manufacturer specified physical densities) overestimated dose transmitted through both the stainless steel bottle (SSB) and the SSCW. After the RED of the SSCW was adjusted to 6.1 (Table 2) Even using the maximum RED value, transmission through the solid part of the SSB is slightly overestimated by AAA.
3.C | Evaluation of the AeroForm TPS model in clinical cases
An example planned dose distribution for Patient 3 is shown in The increased accuracy of the optimized TPS model, used in conjunction with AXB algorithm, has a clinical benefit when applied to patient data. The AeroForm TE presents unique challenges in achieving adequate dose coverage of the target, particularly in the dose shadow and chest wall regions. Advanced treatment planning techniques can be employed to achieve coverage in these areas. However, techniques such as ECOMP, field-in-field, or inverse optimization, rely on accurate dose calculations. This study compared dose calculated by AAA and AXB for ECOMP plans in clinical patient data using the AeroForm TPS model. Dose differences between the two algorithms existed in clinically relevant regions of patient anatomy, such as the dose shadow, and the chest wall. Calculated dose in these areas informs the optimization of the treatment plan, and thus directly affects the design of treatment beams. Beam optimization, and therefore target coverage, will be improved using the optimized TPS model of AeroForm in conjunction with a deterministic dose calculation algorithm such as AXB.
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